While pharmacological, behavioral and psychosocial treatments are available for substance
use disorders (SUDs), they are not always effective or well-tolerated. Neuromodulation (NM) …

Background In recent years, many studies have evaluated the effects of noninvasive brain
stimulation (NIBS) techniques for the treatment of several neurological and psychiatric …

A group of European experts was commissioned to establish guidelines on the therapeutic
use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until …

Substance use disorders (SUDs) are one of the leading causes of morbidity and mortality
worldwide. In spite of considerable advances in understanding the neural underpinnings of …

Multiple sources of evidence support a role for diminished dopaminergic neurotrans-mission
in major depression. The physiological alterations underlying reduced dopa-mine (DA) …

This meta-analysis was conducted to evaluate the available evidence regarding the effects
of non-invasive neurostimulation of the dorsolateral prefrontal cortex (DLPFC), on craving in …

Background Brain dopamine is implicated in the regulation of movement, attention, reward
and learning and plays an important role in Parkinson's disease, schizophrenia and drug …

In this review of the last 5 years' developments in research into depression we focus on
recent advances and current controversies. We cover epidemiology and basic science as …

In Parkinson's disease, the progressive neurodegeneration of nigrostriatal dopaminergic
neurons in the substantia nigra pars compacta (SNc) is associated with classic motor …

The application of a single dose of a CNS active drug with a well-defined mode of action on
a neurotransmitter or neuromodulator system may be used for testing pharmaco …